FDA – Comments submitted to FDA on Rare Diseases: Common Issues in Drug Development

Comments submitted to FDA on Rare Diseases: Common Issues in Drug Development.(Docket Number: FDA-2015-D-2818-0001).

Click here to read the comments and impact on ACRP Members.